EDGEWISE THERAPEUTICS INC's ticker is EWTX and the CUSIP is 28036F105. A total of 85 filers reported holding EDGEWISE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.27 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,688,314 | -35.7% | 6,402,847 | -13.0% | 0.00% | -40.0% |
| Q2 2023 | $57,020,541 | -46.2% | 7,357,489 | -53.7% | 0.01% | 0.0% |
| Q1 2023 | $105,926,830 | +37.9% | 15,881,084 | +84.9% | 0.01% | -37.5% |
| Q4 2022 | $76,787,707 | -2.2% | 8,589,229 | +7.7% | 0.01% | 0.0% |
| Q3 2022 | $78,492,000 | +250.3% | 7,976,813 | +183.3% | 0.01% | +300.0% |
| Q2 2022 | $22,410,000 | -8.4% | 2,815,284 | +11.7% | 0.00% | 0.0% |
| Q1 2022 | $24,458,000 | -36.0% | 2,521,450 | +0.9% | 0.00% | -33.3% |
| Q4 2021 | $38,202,000 | -27.1% | 2,500,099 | -20.7% | 0.00% | -25.0% |
| Q3 2021 | $52,368,000 | +1.7% | 3,154,672 | +30.6% | 0.00% | 0.0% |
| Q2 2021 | $51,517,000 | +3.6% | 2,415,218 | +57.8% | 0.00% | 0.0% |
| Q1 2021 | $49,739,000 | – | 1,530,418 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,553,661 | $8,902,478 | 11.43% |
| Novo Holdings A/S | 6,071,703 | $34,790,858 | 2.57% |
| Orbimed Advisors | 14,567,176 | $83,469,918 | 1.77% |
| Opaleye Management Inc. | 875,405 | $5,016,071 | 1.63% |
| Cormorant Asset Management, LP | 2,946,887 | $16,885,663 | 0.98% |
| DAFNA Capital Management LLC | 519,384 | $2,976,070 | 0.93% |
| EcoR1 Capital, LLC | 3,493,194 | $20,016,002 | 0.68% |
| Deep Track Capital, LP | 2,750,000 | $15,757,500 | 0.61% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,933,137 | $22,536,875 | 0.50% |
| Parkman Healthcare Partners LLC | 473,312 | $2,712,078 | 0.50% |